To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)
This study has been completed.
Information provided by:
First received: June 1, 2007
Last updated: May 20, 2013
Last verified: May 2013
To study different doses of MK0493 for safety, efficacy and tolerability in obese patients.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
Further study details as provided by Merck:
Contacts and Locations